Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor Article

Porter, AC, Sauer, JM, Knierman, MD et al. (2002). Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor . JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 301(3), 1020-1024. 10.1124/jpet.301.3.1020

cited authors

  • Porter, AC; Sauer, JM; Knierman, MD; Becker, GW; Berna, MJ; Bao, JQ; Nomikos, GG; Carter, P; Bymaster, FP; Leese, AB; Felder, CC

sustainable development goals

authors

publication date

  • June 1, 2002

published in

keywords

  • ACID AMIDE HYDROLASE
  • AGONIST
  • BINDS
  • BRAIN
  • CELLS
  • ENDOGENOUS CANNABINOID ANANDAMIDE
  • Life Sciences & Biomedicine
  • Pharmacology & Pharmacy
  • RAT
  • STRIATUM
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS

start page

  • 1020

end page

  • 1024

volume

  • 301

issue

  • 3